Global Value & Access Director, Autoimmune Cell Therapy

1110 Kite Pharma, Inc.; El Segundo (CA); Hybrid; USD 226,000 - 293,000; Full time

Benefits offered by this job

Benefits package

Discretionary bonus

Stock-based long-term incentives

Medical, dental, vision insurance

Job summary

Kite Pharma seeks a Director, Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune. This role leads global market access strategies for autoimmune programs from early development to launch, coordinating with HEOR, Medical Affairs and Commercial teams.

Based in California with a hybrid schedule, you will shape payer perspectives, evidence plans and pricing to support patient access and successful launches across major markets.

Qualifications

• Basic Qualifications: 8+ years with a PhD/ PharmD OR 10+ years with MS/MA, MBA, PharmD, PhD or equivalent OR 12+ years with BS/BA.
• Preferred Qualifications include 3+ years of direct experience in autoimmune programs and deep understanding of autoimmune treatment paradigms.
• Experience with cell therapy or gene therapy and with market access, pricing, reimbursement, HEOR and launch readiness is desirable.
• Ability to influence cross-functional teams in a matrix environment and strong communication skills.

Responsibilities

• Serve as the Global Market Access representative for autoimmune programs and lead the Global and Regional Value Access coordination.
• Develop global value and access strategies across the product lifecycle from development to launch and lifecycle management.
• Ensure payer, HTA, and health system perspectives are reflected in development, pricing, and commercialization strategies.
• Partner with regional teams to translate global access strategies into local reimbursement plans.
• Lead cross-functional assessment of payer requirements and translate insights into actionable recommendations.

Education

8+ years with a PhD/ PharmD OR 10+ years with MS/MA, MBA, PharmD, PhD or equivalent advanced degree OR 12+ years with BS/BA

Job description

Kite Pharma seeks a Director, Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune. This role leads global market access strategies for autoimmune programs from early development to launch, coordinating with HEOR, Medical Affairs and Commercial teams.

Based in California with a hybrid schedule, you will shape payer perspectives, evidence plans and pricing to support patient access and successful launches across major markets.